These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6226808)

  • 1. Prevaccination screening of medical and dental students. Should low levels of antibody to hepatitis B surface antigen preclude vaccination?
    Perrillo RP; Parker ML; Campbell C; Sanders GE; Strang SP; Regenstein F
    JAMA; 1983 Nov; 250(18):2481-4. PubMed ID: 6226808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBV and HCV infection in Japanese dental care workers.
    Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program.
    Su FH; Chen JD; Cheng SH; Lin CH; Liu YH; Chu FY
    J Med Virol; 2007 Feb; 79(2):138-43. PubMed ID: 17177303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers.
    Shim J; Kim KY; Kim BH; Chun H; Lee MS; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
    Vaccine; 2011 Feb; 29(8):1721-6. PubMed ID: 21147128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
    Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
    Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.
    van de Laar TJ; Marijt-van der Kreek T; Molenaar-de Backer MW; Hogema BM; Zaaijer HL
    Transfusion; 2015 Jun; 55(6):1206-13. PubMed ID: 25494685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV; da Silva MA; Calçada Cde O; Cavalcante SR; Souto FJ
    Vaccine; 2011 Jul; 29(32):5290-3. PubMed ID: 21605613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs.
    Lok AS; Lai CL; Wu PC
    Hepatology; 1988; 8(4):766-70. PubMed ID: 2968945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimization of hepatitis B infection by a 25-year universal vaccination program.
    Ni YH; Chang MH; Wu JF; Hsu HY; Chen HL; Chen DS
    J Hepatol; 2012 Oct; 57(4):730-5. PubMed ID: 22668640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anti-HBc in anti-HBs positive individuals: implications for selecting vaccine candidates.
    Hanson M; Polesky HF
    Am J Clin Pathol; 1984 Dec; 82(6):716-9. PubMed ID: 6239539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
    Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
    S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to hepatitis B virus in the general population of Hisayama, Japan: significance of isolated antibody to hepatitis B surface antigen in general population.
    Kajiwara E; Akagi K; Ueda K; Murai K; Hasuo Y; Kiyohara Y; Wada J; Kawano H; Kato I; Fujishima M
    Fukuoka Igaku Zasshi; 1992 Jun; 83(6):250-6. PubMed ID: 1511950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.